A complete list of precautions and medication contraindications during the use of Lebolaysin (Davico)

1. Drug Overview and Mechanism of Action

Lemborexant is an oral dual orexin receptor antagonist (Dual Orexin Receptor Antagonist, DORA), which mainly blocks orexin (orexin A and orexin B) receptors reduce the transmission of arousal signals, thereby promoting natural sleep. It is different from traditional benzodiazepines or Z sleeping pills and is less likely to cause dependence and withdrawal reactions. Therefore, it is widely used in the treatment of adult insomnia, especially for patients with long-term difficulty falling asleep or maintaining sleep. Despite this, there are still many safety precautions and medication contraindications that need to be paid attention to when using leborexan to ensure efficacy and reduce risks.

2. Precautions during use

1.Strictly follow the doctor's instructions: Leborexan is a prescription drug, and the recommended dosage is usually 5mg or 10mg, taken before bedtime, and must be taken at least 7 More than 7 hours of sleep, otherwise adverse effects such as drowsiness, slow reaction, and decreased concentration may occur the next day.

2.Avoid dangerous work: Taking medication may cause residual drowsiness or impaired cognitive function the next day. Therefore, you should evaluate your own status before driving, operating machinery, or work that requires high alertness to avoid safety risks.

3.Pay attention to individual differences: Different patients have great differences in drug sensitivity. The elderly, underweight people or people with reduced liver function are more likely to suffer from excessive sedation and the risk of falling. Therefore, it is necessary to start with a low dose and gradually adjust if necessary.

4.Monitor the long-term effects: If there is no significant improvement after continuous use for more than 7–10 days, you should follow up for a follow-up consultation in time to check for potential mental disorders, depression or other diseases that affect sleep, rather than blindly increasing the dosage.

3. Possible adverse reactions and risk warnings

Leborexan is generally well tolerated, but some patients may still experience adverse reactions and need to be informed in advance:

1.The most common reactions: drowsiness, dizziness, fatigue, and difficulty concentrating the next day.

2. Central nervous system effects: Some patients may report hallucinations and abnormal dreams, especially when awakening suddenly during the night.

3.Risk of falls: Among the elderly, balance disorders caused by drugs and the probability of falling when standing up at night increase.

4.Cognitive and memory problems: Individual cases suggest that short-term memory loss may occur, and attention should be paid to distinguishing it from the impact of underlying diseases.

5. Dependence and tolerance: Although the risk is lower than traditional sleeping pills, long-term use of large doses may still lead to dependence, and you should avoid increasing the dose on your own.

4. Drug interactions and drug conflict avoidance

1.CYP3AMetabolic effects: Leborexen is mainly metabolized by liverCYP3Aenzyme.

2.Combined use with potent CYP3A inhibitors (such as ketoconazole, itraconazole, clarithromycin) will significantly increase the blood concentration and increase the risk of side effects, and should generally be avoided.

3.Combined use with potent CYP3A inducers (such as rifampicin, carbamazepine, phenytoin) will reduce the efficacy of the drug, and combined use is not recommended.

4. Risks of combined use of central depressants: When combined with alcohol, benzodiazepines, opioid analgesics or other hypnotics, it will enhance the central depressant effect and increase the risk of over-sedation, respiratory depression and falls, and should be strictly avoided.

5.Combined use with antidepressants: Some antidepressants (such as SSRIs, SNRIs) themselves have a certain effect on sleep. When combined with leborexan, they may aggravate drowsiness, and the dose needs to be adjusted.

5. Medication precautions for special groups

1.The elderly: are more sensitive to drugs and often require low doses (such as 5mg starting) to reduce the risk of falls and cognitive impairment.

2.Patients with impaired liver function: Patients with moderate liver impairment should use it with caution, and patients with severe liver impairment (Child-Pugh C grade) should not use it.

3.Pregnant and lactating women: There is a lack of sufficient human clinical safety data, and animal experiments suggest there may be risks to fetal development. Unless the potential benefits far outweigh the risks, use is not recommended.

4.Children and Adolescents: Not currently approved for 18 There is a lack of safety and efficacy data for people under the age of 18.

5. Patients with mental illness: Patients with severe depression, schizophrenia or suicidal tendencies should use it with caution, as the drug may mask or aggravate mental symptoms.

6. Medication contraindications and strict prohibitions

It is prohibited for those who are allergic to this product or its excipients.

It is contraindicated in patients with severe liver damage because the drug metabolism ability is significantly reduced and the risks outweigh the benefits.

It is contraindicated for patients to use strongCYP3A inhibitors at the same time. Excessive increase in blood concentration may lead to serious adverse reactions.

It is contraindicated in patients with severe respiratory dysfunction (such as patients with severe obstructive sleep apnea and patients with severe chronic obstructive pulmonary disease), because the drug can further inhibit the awakening reflex and increase the risk of hypoxia.

It is contraindicated in patients with acute alcohol or drug intoxication, as the superimposed drug effects may cause dangerous central depression.

7. Summary and clinical management suggestions

Leborexan, as a new type of insomnia treatment drug, has improved safety compared with traditional sleeping drugs. However, in clinical use, the dosage and medication time still need to be strictly controlled, and combination with CYP3A related drugs and central depressants must be avoided. For the elderly, patients with liver impairment, and those with a history of mental illness, individualized risk assessment is required. Patients should use medications regularly under the guidance of professional doctors and pay attention to the occurrence of adverse reactions at any time. Only through rational medication use and timely follow-up can we truly take advantage of the advantages of Lebraxant in improving sleep while minimizing potential risks.

Reference link:https://www.drugs.com